Influenza can result in serious complications, hospitalization, and death. Annual vaccination is the primary means of preventing influenza and is recommended by the Centers for Disease Control and Prevention (CDC).7
People at high risk
Children aged 6 through 35 months
Adults aged 65 years and older
In recent years, the CDC estimates people aged 65 years and older have accounted for10:
Other high-risk groups
For more information about influenza and high-risk populations, please visit the CDC.
|*||The CDC analyzed data sourced from the National Immunization Survey-Flu (NIS-Flu) with an unweighted sample size of 37,626 subjects aged 6 months to 4 years.9|
FAQs for FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT (Influenza Vaccine)
FLULAVAL and FLUARIX are registered trademarks of the GSK group of companies.
FLULAVAL QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FLULAVAL QUADRIVALENT is approved for use in persons aged 6 months and older.